BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$672M |
| 2 |
Microsoft
MSFT
|
+$541M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$441M |
| 4 |
Pfizer
PFE
|
+$425M |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$420M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$805M |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$535M |
| 3 |
Lam Research
LRCX
|
+$482M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$359M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.25% |
| 2 | Financials | 7.39% |
| 3 | Consumer Discretionary | 7.31% |
| 4 | Healthcare | 6.72% |
| 5 | Communication Services | 5.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Orthofix Medical
OFIX
$421M
| $543K | ﹤0.01% |
34,758
+9,456
| +37% | +$151K |
|
2702
Acadia Realty Trust
AKR
$2.86B
| $539K | ﹤0.01% |
22,969
+253
| +1% | +$5.39K |
|
2703
First Bancorp
FBNC
$2.74B
| $539K | ﹤0.01% |
12,956
+4,838
| +60% | +$193K |
|
2704
Immersion
IMMR
$249M
| $539K | ﹤0.01% |
60,404
-7,243
| -11% | -$73.7K |
|
2705
IMAX
IMAX
$2.9B
| $537K | ﹤0.01% |
26,161
-1,824
| -7% | -$35.9K |
|
2706
Surgery Partners
SGRY
$1.97B
| $536K | ﹤0.01% |
16,616
-84,424
| -84% | -$2.49M |
|
2707
American Superconductor
AMSC
$1.55B
| $535K | ﹤0.01% |
22,679
-24,961
| -52% | -$575K |
|
|
VLRS
2708
Controladora Vuela Compania de Aviacion
VLRS
$906M
| $533K | ﹤0.01% |
84,252
+51,580
| +158% | +$314K |
|
2709
Agios Pharmaceuticals
AGIO
$2B
| $531K | ﹤0.01% |
11,946
+1,570
| +15% | +$71.3K |
|
|
GRFS
2710
Grifois
GRFS
$5.29B
| $529K | ﹤0.01% |
59,577
-75,576
| -56% | -$615K |
|
2711
Franklin Covey
FC
$229M
| $527K | ﹤0.01% |
12,810
+7,606
| +146% | +$305K |
|
|
DMC
2712
Del Monte Corp
DMC
$1.43B
| $525K | ﹤0.01% |
17,768
-9,941
| -36% | -$263K |
|
2713
BioLife Solutions
BLFS
$1.72B
| $522K | ﹤0.01% |
20,845
-16,880
| -45% | -$399K |
|
2714
CONMED
CNMD
$1.51B
| $522K | ﹤0.01% |
7,253
-2,472
| -25% | -$174K |
|
2715
Talos Energy
TALO
$2.63B
| $521K | ﹤0.01% |
50,316
+36,356
| +260% | +$414K |
|
2716
S&T Bancorp
STBA
$1.8B
| $520K | ﹤0.01% |
12,396
+4,929
| +66% | +$200K |
|
|
DX
2717
Dynex Capital
DX
$3.24B
| $517K | ﹤0.01% |
40,502
+24,139
| +148% | +$298K |
|
|
KE
2718
Kimball Electronics
KE
$622M
| $516K | ﹤0.01% |
27,898
+20,385
| +271% | +$408K |
|
2719
ArriVent BioPharma
AVBP
$1.37B
| $516K | ﹤0.01% |
21,965
+5,397
| +33% | +$123K |
|
2720
Old Second Bancorp
OSBC
$1.32B
| $514K | ﹤0.01% |
32,967
+24,084
| +271% | +$388K |
|
|
SAGE
2721
DELISTED
Sage Therapeutics
SAGE
| $513K | ﹤0.01% |
70,986
+24,356
| +52% | +$223K |
|
2722
White Mountains Insurance
WTM
$5.1B
| $511K | ﹤0.01% |
301
+202
| +204% | +$352K |
|
|
NFBK
2723
DELISTED
Northfield Bancorp
NFBK
| $508K | ﹤0.01% |
43,809
+35,751
| +444% | +$410K |
|
2724
Stepan Co
SCL
$1.48B
| $508K | ﹤0.01% |
6,577
-1,894
| -22% | -$150K |
|
2725
PUT
Zillow
ZG
$7.91B
| $508K | ﹤0.01% |
+82
| New | +$4.27K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2024 Portfolio in Review
As of Q3 2024, BNP Paribas Financial Markets held 4,296 positions worth $149B, up 21% from $123B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
BNP Paribas Financial Markets's Q3 2024 filing shows 266 new, 2,153 increased, 1,264 reduced and 157 closed positions. Its largest new stake was Ferguson: 319,382 shares worth $63.4M. The largest sale was Visa, an estimated $805M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q3 2024 buy was Ferguson: 319,382 shares worth $63.4M.
- BNP Paribas Financial Markets added most to NVIDIA in Q3 2024, an estimated $672M increase.
- BNP Paribas Financial Markets's biggest Q3 2024 reduction was Visa, cutting an estimated $805M.
- BNP Paribas Financial Markets fully exited Lam Research in Q3 2024, selling an estimated $482M.
- BNP Paribas Financial Markets's ten largest holdings make up 20% of its $149B portfolio in Q3 2024.
- BNP Paribas Financial Markets opened 266 new positions and closed 157 in Q3 2024.
- BNP Paribas Financial Markets's portfolio value rose 21% quarter-over-quarter to $149B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2024, filed 13 Nov 2024.